Benjamin R. Brenner

Q: What Schools Are Affiliated With Benjamin R. Brenner

Benjamin R. Brenner is affiliated with the following schools: Technion – Israel Institute of Technology, University of Perugia, First Moscow State Medical University, University of Rochester

Benjamin R. Brenner's AcademicInfluence.com Rankings

Benjamin R. Brenner

Philosophy

#6707

World Rank

#9794

Historical Rank

Logic

#3831

World Rank

#5049

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Benjamin R. Brenner's Degrees

Doctorate Medicine University of California, San Francisco
Masters Public Health University of California, Berkeley

Why Is Benjamin R. Brenner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Benjamin R. Brenner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Oral rivaroxaban for symptomatic venous thromboembolism. (2010) (2225)
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial (2008) (1115)
Fibrinolysis for patients with intermediate-risk pulmonary embolism. (2014) (1108)
Haemostatic changes in pregnancy. (2004) (708)
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer (2013) (636)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. (2020) (484)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. (2019) (359)
Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial (2008) (313)
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. (2016) (311)
Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. (1996) (285)
Gestational Outcome in Thrombophilic Women with Recurrent Pregnancy Loss Treated by Enoxaparin (2000) (284)
Fondaparinux for the treatment of superficial-vein thrombosis in the legs. (2010) (277)
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer (2012) (271)
Thrombophilic Polymorphisms Are Common in Women with Fetal Loss without Apparent Cause (1999) (261)
A single genetic origin for a common Caucasian risk factor for venous thrombosis. (1997) (250)
Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. (2002) (222)
Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells (2008) (217)
Overview of hemostasis (2002) (205)
Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE‐ENOX study (2005) (204)
Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study (2007) (202)
Haematological cancers in pregnancy (2012) (144)
Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE) (2018) (134)
Cardiac involvement in patients with primary antiphospholipid syndrome. (1991) (127)
Increased risk of cancer in patients with gaucher disease (1993) (123)
A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. (2006) (121)
A Missense Mutation in γ-Glutamyl Carboxylase Gene Causes Combined Deficiency of All Vitamin K-Dependent Blood Coagulation Factors (1998) (120)
Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation. (2004) (118)
Microparticles, thrombosis and cancer. (2009) (114)
Involvement of microparticles in diabetic vascular complications (2011) (113)
Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts. (2016) (113)
Thrombophilia-associated pregnancy wastage. (1999) (109)
Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation (2005) (108)
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study (2018) (108)
Prophylactic therapy with enoxaparin during l-asparaginase treatment in children with acute lymphoblastic leukemia (2000) (107)
Activated Protein C Resistance and Factor V Leiden Mutation can be Associated with First‐ as well as Second‐Trimester Recurrent Pregnancy Loss 1 (2000) (106)
The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. (1997) (103)
Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. (2011) (102)
Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus (2009) (98)
Heparanase, heparin and the coagulation system in cancer progression. (2007) (93)
Dental surgery in patients with severe factor XI deficiency without plasma replacement. (1992) (91)
Pulmonary hemorrhage: A novel mode of therapy. (2009) (90)
Paediatric cerebral sinus vein thrombosis (2004) (90)
Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX. (1994) (89)
Tissue factor and cancer. (2008) (88)
Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis (2004) (88)
Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. (2009) (87)
Inherited Thrombophilia and Pregnancy Loss (1999) (86)
Bleeding and thrombosis in acute leukemia: what does the future of therapy look like? (2007) (78)
Venous thromboembolism during pregnancy, postpartum or during contraceptive use (2009) (76)
Cryogenic Transmission Electron Microscopy Nanostructural Study of Shed Microparticles (2013) (76)
Familial thrombophilia--the scientific rationale for thrombophylaxis in recurrent pregnancy loss? (1997) (76)
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients. (2005) (75)
Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells (2008) (74)
Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. (1997) (73)
Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. (2010) (71)
Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. (2005) (70)
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial. (2018) (69)
Procoagulant and anticoagulant mechanisms in human placenta. (2003) (69)
A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. (1998) (69)
Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions. (1998) (69)
Clinical management of thrombophilia-related placental vascular complications. (2004) (68)
Thrombophilia and pregnancy loss. (2002) (67)
Cancer and thrombosis revisited. (2001) (66)
Angiosarcoma of the colon developing in a capsule of a foreign body. Report of a case with associated hemorrhagic diathesis. (1992) (66)
Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII (2010) (64)
Vitamin K-dependent coagulation factors deficiency. (2009) (63)
The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation (2000) (63)
Hereditary deficiency of all vitamin K‐dependent procoagulants and anticoagulants (1990) (63)
Heparanase multiple effects in cancer. (2014) (61)
HELLP syndrome associated with factor V R506Q mutation (1996) (59)
Haemostatic mechanisms in human placenta. (2003) (56)
Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs (2012) (55)
Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom. (2005) (54)
Microvesicles of Women With Gestational Hypertension and Preeclampsia Affect Human Trophoblast Fate and Endothelial Function (2013) (54)
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life (2004) (54)
Evaluation of solvent/detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders (1993) (54)
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE (2017) (53)
Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System (2008) (53)
Thrombophilia and fetal loss. (2003) (52)
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications (2004) (52)
In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. (1990) (52)
Thrombohemorrhagic complications of myeloproliferative disorders. (2010) (51)
Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis (1996) (51)
The Effect of Combined Factor XI Deficiency with von Willebrand Factor Abnormalities on Haemorrhagic Diathesis (1990) (51)
Inherited thrombophilia and poor pregnancy outcome. (2003) (50)
Bleeding predictors in factor‐XI‐deficient patients (1997) (50)
Application of a bedside whole blood D‐dimer assay in the diagnosis of deep vein thrombosis (1995) (49)
Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. (2002) (48)
High incidence of myeloproliferative disorders in Ashkenazi Jews in northern Israel. (1992) (48)
Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III (1988) (48)
Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor. (2005) (48)
Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesis (2018) (46)
Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine? (2014) (45)
Arterial thrombosis and cancer. (2018) (45)
Microparticles and pregnancy complications. (2011) (44)
Inherited thrombophilia and fetal loss. (2000) (44)
Adverse obstetric and neonatal outcomes in women with mental disorders. (2015) (43)
Neonatal IVH--mechanisms and management. (2011) (41)
Prevalence of Upper Extremity Deep Venous Thrombosis Diagnosed by Color Doppler Duplex Sonography in Cancer Patients With Central Venous Catheters (2006) (41)
Drug-related thrombosis in hematologic malignancies. (2004) (41)
Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus. (1988) (40)
Ala244Val Is a Common, Probably Ancient Mutation Causing Factor VII Deficiency in Moroccan and Iranian Jews (1996) (40)
Thrombophilia and Cancer (2007) (40)
Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism. (2018) (40)
Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review. (2013) (39)
Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism (2017) (38)
SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia (2021) (38)
Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation. (1990) (38)
Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations. (1997) (37)
Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment. (2009) (37)
Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. (1996) (36)
Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss (2005) (36)
A direct-imaging cryo-EM study of shedding extracellular vesicles from leukemic monocytes. (2017) (36)
Expression and Characterization of the Naturally Occurring Mutation L394R in Human γ-Glutamyl Carboxylase* (2000) (36)
Control of Bleeding Caused by Thrombocytopenia Associated With Hematologic Malignancy: An Audit of the Clinical Use of Recombinant Activated Factor VII (2005) (35)
Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis (1996) (35)
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 (2022) (34)
Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency (2007) (34)
Heparanase procoagulant activity in cancer progression. (2016) (33)
Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss (2006) (33)
Magnetic resonance imaging of blood and clots in vitro. (1990) (32)
Von Willebrand Factor Multimer Patterns in Pregnancy-Induced Hypertension (1989) (32)
Visual disturbances and pathologic ocular findings in primary antiphospholipid syndrome. (1999) (31)
Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects? (2014) (30)
Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study (2018) (30)
Angioedema during therapy with recombinant tissue plasminogen activator. (1991) (30)
VTE Registry: What Can Be Learned from RIETE? (2014) (30)
Assessment and management of high-risk pregnancies in women with thrombophilia. (2009) (29)
JAK-2 V617F mutation increases heparanase procoagulant activity (2015) (29)
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. (2016) (29)
Inherited thrombophilia and pregnancy loss. (2003) (28)
Renal extramedullary hematopoiesis simulating hypernephroma. (1991) (27)
Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis. (1992) (27)
Tumor‐derived microparticles induce bone marrow‐derived cell mobilization and tumor homing: A process regulated by osteopontin (2014) (27)
Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration. (1998) (27)
Hereditary protein C deficiency during pregnancy. (1987) (27)
Characterization of negatively charged phospholipids and cell origin of microparticles in women with gestational vascular complications. (2012) (26)
Diagnosis of femoropopliteal venous thrombosis with MR imaging: a comparison of four MR pulse sequences. (1990) (26)
Hereditary Deficiency of Vitamin K-dependent Coagulation Factors (2000) (26)
Thrombotic complications associated with stem cell transplantation. (2012) (26)
Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry (2018) (26)
Dehydration as a Possible Cause of Monthly Variation in the Incidence of Venous Thromboembolism (2016) (26)
An assay to evaluate heparanase procoagulant activity. (2011) (25)
Incidence, prognostic significance and therapeutic modalities of central nervous system involvement in multiple myeloma. (1982) (25)
Relation of plasma D-dimer concentrations to coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction. (1989) (25)
Spontaneous intracranial hemorrhage in immune thrombocytopenic purpura. (1988) (25)
Emerging options in the treatment of deep vein thrombosis and pulmonary embolism. (2011) (25)
Heparanase coagulation and cancer progression. (2009) (25)
Protein C Global Assay in the Evaluation of Women with Idiopathic Pregnancy Loss (2002) (24)
Lower limb ischaemia in primary antiphospholipid syndrome. (1993) (24)
An Update on the Management of Hematologic Malignancies in Pregnancy (2014) (24)
Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients. (2014) (23)
Hypercoagulation in chronic post-traumatic stress disorder. (2011) (23)
Thrombophilia and adverse pregnancy outcome. (2006) (23)
Low-Molecular-Weight Heparin in Women with Repeated Implantation Failure (2011) (23)
Intraventricular hemorrhage in preterm infants: coagulation perspectives. (2011) (23)
Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation. (2000) (23)
Disease dynamics in patients with acute myeloid leukemia: new biomarkers. (2015) (23)
Asymptomatic deep vein thrombosis in advanced cancer patients: The value of venous sonography (2010) (22)
Red wine consumption improves in vitro migration of endothelial progenitor cells in young, healthy individuals. (2010) (22)
Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases. (1988) (22)
Hemostasis in normal pregnancy. (2005) (22)
Heparanase, tissue factor, and cancer. (2008) (22)
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism (2017) (22)
Involvement of Heparanase in early pregnancy losses. (2010) (22)
Factor XIII Deficiency due to a Leu660Pro Mutation in the Factor XIII Subunit-a Gene in Three Unrelated Palestinian Arab Families (1997) (21)
Hemorrhagic and thrombotic complications in bone marrow transplant recipients. (2007) (21)
Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model (2016) (21)
Thrombophilia and pregnancy complications (2004) (21)
COMMENTARY: Thrombophilia and pregnancy loss in first intended pregnancy (2005) (21)
The promise of novel direct oral anticoagulants. (2012) (21)
Coagulation, inflammation, and pregnancy complications (2004) (21)
Intraventricular hemorrhage in preterm infants and coagulation--ambivalent perspectives? (2013) (21)
Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia (2003) (20)
Expression and characterization of the naturally occurring mutation L394R in human gamma-glutamyl carboxylase. (2000) (20)
Extended Thromboprophylaxis with Rivaroxaban Compared with Short-Term Thromboprophylaxis with Enoxaparin after Total Hip Arthroplasty: The RECORD2 Trial. (2007) (20)
Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic events (2002) (20)
Novel peptides that inhibit heparanase activation of the coagulation system (2014) (20)
Interventions to prevent venous thrombosis after air travel, are they necessary? Yes (2006) (20)
Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function. (2016) (20)
Heparanase procoagulant activity is elevated in women using oral contraceptives. (2013) (20)
Multiple myeloma with pericardial involvement and cardiac tamponade: a report of three patients. (1996) (19)
Involvement of the heparanase procoagulant domain in bleeding and wound healing (2017) (19)
Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries. (2014) (19)
CILIORETINAL ARTERY OCCLUSION: An Ocular Complication of Primary Antiphospholipid Syndrome (1997) (19)
Successful Use of Recombinant Activated Factor VII (Novoseven®) in Controlling Severe Intra-Abdominal Bleeding after Liver Needle Biopsy (2002) (19)
Extracellular Vesicle Characteristics in β-thalassemia as Potential Biomarkers for Spleen Functional Status and Ineffective Erythropoiesis (2018) (18)
Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia. (1986) (18)
Involvement of heparanase in vaginal and cesarean section deliveries. (2010) (18)
Budd-Chiari syndrome associated with factor V leiden mutation: a report of 6 patients. (1999) (18)
Pulmonary embolism: Epidemiology and registries. (2015) (18)
Acquired thrombophilic syndromes. (2001) (18)
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients (2019) (18)
The coagulation profile of preterm delivery. (2014) (18)
Extracellular Vesicles of Alzheimer’s Disease Patients as a Biomarker for Disease Progression (2020) (18)
A fatal case of enoxaparin induced skin necrosis and thrombophilia (2006) (18)
Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks (2016) (18)
SARS-CoV-2 vaccine and thrombosis: Expert opinions. (2021) (18)
Activation of coagulation in amniotic fluid during normal human pregnancy. (2011) (18)
Comparison of international societal guidelines for the diagnosis of suspected pulmonary embolism during pregnancy. (2020) (17)
Coagulation and Placenta-Mediated Complications (2014) (17)
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19 (2020) (17)
Management of pregnant women with myeloproliferative neoplasms. (2013) (17)
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer (2021) (17)
Heparanase level and procoagulant activity are reduced in severe sepsis (2018) (17)
Thrombin is a selective inducer of heparanase release from platelets and granulocytes via protease-activated receptor-1 (2017) (17)
Increased immunoreactivity of plasma after fibrinolytic activation in an anti-DD ELISA system. Role of soluble crosslinked fibrin polymers. (1989) (17)
Characterization of Three Mutations Causing von Willebrand Disease Type IIA in Five Unrelated Families (1992) (16)
Corpus Luteum Hemorrhage in Women with Bleeding Disorders (2009) (16)
Molecular characterization of four novel mutations causing factor VII deficiency. (2000) (16)
Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin. (2012) (16)
The role of fibrin matrices and tissue factor in early-term trophoblast proliferation and spreading. (2013) (15)
Thrombophilia and fetal loss. (1997) (15)
Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy (2006) (14)
Prolonged travel and venous thromboembolism findings from the RIETE registry. (2010) (14)
Mental Disorders and Thrombotic Risk (2013) (14)
Venous Sonography for the Diagnosis of Asymptomatic Deep Vein Thrombosis in Patients With Cancer Undergoing Chemotherapy (2004) (14)
Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpura (2007) (14)
Thrombophilia related issues in women and children. (2005) (14)
Coinfection with hepatitis viruses and human immunodeficiency virus in multiply transfused patients. (1994) (13)
Chemotherapy administration to breast cancer patients affects extracellular vesicles thrombogenicity and function. (2017) (13)
Clinical experience with Octagam, a solvent detergent (SD) virus inactivated intravenous gammaglobulin. (1996) (13)
Glanzmann thrombasthenia in two Iraqi-Jewish siblings is caused by a novel splice junction mutation in the glycoprotein IIb. (1998) (13)
The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice. (2018) (13)
The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests. (1989) (13)
Coagulation and Mental Disorders (2014) (13)
Acute leukemia following chemotherapy and radiation therapy--a report of 15 cases. (1984) (13)
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill (2019) (13)
Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry. (2016) (13)
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy. (2014) (12)
Grb2 regulates the proliferation of hematopoietic stem and progenitors cells. (2017) (12)
Heparanase procoagulant activity. (2012) (12)
Heparanase—A Link between Coagulation, Angiogenesis, and Cancer (2012) (12)
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation. (2017) (11)
Heparanase procoagulant effects and inhibition by heparins. (2010) (11)
Cilioretinal artery occlusion: an ocular complication of primary antiphospholipid syndrome. (1997) (11)
p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restriction (2017) (11)
Extracellular Vesicles Reflect the Efficacy of Wheatgrass Juice Supplement in Colon Cancer Patients During Adjuvant Chemotherapy (2020) (11)
Effects of Acute Stress on Thrombosis (2018) (11)
Antiphospholipid Antibodies: Neuropsychiatric Presentations (2013) (11)
High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death. (1999) (11)
Placenta-derived microparticles. (2013) (11)
Presence of Integrin alpha(IIb)beta 3 in early gestation human trophoblasts: possible involvement of fibrin as a matrix ligand. (2010) (11)
COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations (2020) (11)
Intraventricular haemorrhage in preterm infants – Can we improve outcome by addressing coagulation? (2015) (11)
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes (2003) (11)
The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper (2021) (11)
Immune-Mediated Coagulopathy in COVID-19 Infection (2020) (11)
Hydration does not prevent orthostatic hypercoagulability (2009) (11)
Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients. (2006) (10)
Platelet activation in patients with antiphospholipid syndrome. (1998) (10)
Management of acute myeloid leukemia during pregnancy. (2014) (10)
Thrombophilia and adverse pregnancy outcome. (2007) (10)
Fertility, Infertility and Thrombophilia (2011) (10)
Women, thrombosis, and cancer: A gender-specific analysis. (2017) (10)
Evaluation of the Protein C Global Assay During Normal Pregnancy and After Assisted Reproduction (2010) (9)
Prophylaxis of travel-related thrombosis in women. (2009) (9)
Prophylaxis for travel‐related thrombosis? Yes (2004) (9)
Inhalation of a Short-Acting β2-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects (2016) (9)
Do we need a cancer screening in patients with idiopathic deep vein thrombosis? (2009) (9)
Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses (2015) (9)
Thrombosis in hematological malignancies: mechanisms and implications. (2020) (9)
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry. (2019) (9)
Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. (2004) (9)
Letter to the editor: Prophylaxis of thromboembolism during pregnancy in hereditary AT‐III deficiency (1992) (9)
Hypercoagulability, Parkinsonism, and Gaucher Disease (2013) (9)
Implementing Thrombosis Guidelines in Cancer Patients: A Review (2014) (9)
Partial response of meningeal myeloma to craniospinal radiotherapy (1986) (9)
Thrombosis in vasculitic disorders-clinical manifestations, pathogenesis and management. (2015) (8)
Chemotherapy administration to breast cancer patients affects extracellular vesicles thrombogenicity and function (2017) (8)
Neurocognitive dysfunction in the antiphospholipid antibody syndrome (APS) (1996) (8)
Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial (2020) (8)
Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation. (2016) (8)
Did Jesus Christ die of pulmonary embolism? (2005) (8)
Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia. (2020) (8)
Small intestinal myeloid metaplasia. (1988) (8)
[Spontaneous umbilical cord hematoma]. (2005) (7)
The Chemokine Stromal Cell–Derived Factor-1&agr; Promotes Endothelial Progenitor Cell–Mediated Neovascularization of Human Transplanted Fat Tissue in Diabetic Immunocompromised Mice (2013) (7)
[Primary hypercoagulable states]. (1987) (7)
Effects of Low- and High-Dose Chemotherapy Agents on Thrombogenic Properties of Extracellular Vesicles Derived from Breast Cancer Cell Lines (2018) (7)
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives (2021) (7)
Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia. (2021) (7)
Hypercoagulability and recurrent miscarriages. (2010) (7)
Cancer and Thrombosis—New Insights (2018) (7)
Oral and Poster Presentations (2003) (7)
Combined Thrombophilia and Obstetric Complications (2009) (7)
D‐dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry (2020) (7)
Pancoast's syndrome in multiple myeloma. (1984) (6)
Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly (2021) (6)
The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism. (2015) (6)
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years (2019) (6)
Clinical significance of prothrombin G20210A mutation in homozygous patients (2017) (6)
Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia. (1987) (6)
Adult hemolytic uremic syndrome associated with nonimmune deposit crescentic glomerulonephritis and alveolar hemorrhage. (1988) (6)
Thrombophilia and pregnancy. (2003) (6)
Novel strategies of coagulation inhibition for reducing tumor growth and angiogenesis. (2018) (6)
P.76 Low molecular weight heparin in women with repeated implantation failure (2011) (6)
Thrombophilia and pregnancy (2003) (6)
COVID-19, hemostasis disorders and risk of thrombotic complications (2020) (6)
Enoxaparin Use in Pregnancy: State of the Art (2007) (6)
Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. (1992) (6)
The association between poor ovarian response and thrombophilia in assisted reproduction. (2013) (6)
Microvesicles in Thrombosis and Inflammation. (2016) (6)
"To drink or not to drink" – is this really the question? (2008) (5)
Arterial thrombotic syndromes in cancer patients. (2001) (5)
Maternal anticoagulant prophylaxis for prevention of pregnancy loss in women with thrombophilia (2003) (5)
Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy. (1985) (5)
Monitoring of Therapy for Deep Vein Thrombosis Using Magnetic Resonance Imaging (1989) (5)
Extracellular Vesicle MicroRNA That Are Involved in β-Thalassemia Complications (2021) (5)
Women's issues in thrombosis and hemostasis (2002) (5)
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study (2017) (5)
Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study. (2022) (5)
Cancer in pregnancy: the role of thromboprophylaxis. (2012) (5)
Efficacy of enoxaparin for improving pregnancy outcomes and uteroplacental blood flow in women with thrombophilia and recurrent pregnancy loss (2004) (5)
Microparticles and placental hemostasis. (2009) (4)
[Thrombolytic therapy in deep vein thrombosis]. (1991) (4)
Malignancies in Pregnancy 3 Haematological cancers in pregnancy (2012) (4)
Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in the Treatment of Bleeding Complications Following Hematopoietic Stem Cell Transplantation (HSCT). (2004) (4)
Anticoagulants and chronic kidney disease. (2011) (4)
Recurrent spontaneous bacterial peritonitis in a patient with polycythemia vera (1988) (4)
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism (2021) (4)
Von Willebrand Factor Antigen and Factor XI Activity Levels As Predictors of Bleeding Tendency in Israeli Patients with Von Willebrand's Disease (1995) (4)
The role of the fibrinolytic system in female reproductive disorders and depression (2020) (4)
A novel mutation of antithrombin deficiency in six family siblings and the clinical combat (2015) (4)
Coagulation and Brain (2013) (4)
Thrombophilia and Pregnancy Complications (2006) (4)
Carbamazepine (Tegretol)‐Induced Thrombocytopenia (1993) (4)
Thrombophilia in Infancy: Factor V Leiden and MTHFR or Factor II Double Heterozygocity as a Risk Factor (2003) (4)
Malignancies in Pregnancy 3 Haematological cancers in pregnancy (2012) (4)
Outcome of cancer-associated venous thromboembolism is more favorable among patients with hematologic malignancies than in those with solid tumors. (2022) (3)
Eosinophilic fibrohistiocytic lesion of bone marrow associated with monoclonal gammopathy and osteolytic lesions (1986) (3)
Thrombophilia and cancer in the pathogenesis of arterial thrombosis (2000) (3)
New insights into paediatric haemostasis: thrombosis and bleeding issues (2004) (3)
[Is there an association between PUPPP and preeclampsia, abruptio placentae and fetal death?]. (2004) (3)
Reduced protein C Global assay level in infertile women prior to IVF-ET treatment (2013) (3)
Approach to the Evaluation and Treatment of Venous Thromboembolism in Pregnancy (2021) (3)
Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia. (2017) (3)
The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs. (1991) (3)
A study of coagulation and anti-endothelial antibodies in idiopathic livedo reticularis. (1997) (3)
Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism (2020) (3)
PAR1 Expression Predicts Clinical G-CSF CD34+ HSPC Mobilization and Repopulation Potential in Transplanted Patients (2019) (3)
A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: A derivation cohort analysis. (2022) (3)
Abstract 10672: Incidence of Major Adverse Cardiovascular Events Among Patients With Provoked and Non-Provoked Venous Thromboembolism: A Review of the RIETE Registry (2018) (2)
Early Bone Marrow Examination, On The Fifth Day Of Induction For AML, Is Highly Predictive Of Response (2013) (2)
Hemostasis and Thrombosis in Extreme Physiological and Pathological Conditions (2018) (2)
[Colonoscopy for early detection of colorectal cancer in average-risk population]. (2006) (2)
Thrombophilia in pregnancy and its role in abortion. (2005) (2)
Microparticles Induce Procoagulant and Apoptotic Effects on Endothelial Cells. (2006) (2)
Myeloma and thrombotic complications. (2013) (2)
Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETE (2020) (2)
PO-46 - Influence of extracellular vesicles derived from AML patients on stem cells and their microenvironment. (2016) (2)
Travel-related thrombosis: is this a problem? (2006) (2)
Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need (2022) (2)
Increased Heparanase Level and Procoagulant Activity in Orthopedic Surgery Patients Receiving Prophylactic Dose of Enoxaparin (2011) (2)
[Symptomatic antiphospholipid antibody after neuroleptic drugs]. (1995) (2)
State-of-the-art thrombosis prevention and treatment (2008) (2)
Antithrombin III and preeclampsia. (1990) (1)
The Use of Recombinant Factor VIIa in Platelet Disorders: Thrombocytopenia and Thrombocytopathia (2003) (1)
[EXPERIENCE IN DIAGNOSTIC ASSAYS FOR HEPARIN-INDUCED THROMBOCYTOPENIA - EXPERIENCE OF A TERTIARY HOSPITAL IN ISRAEL]. (2019) (1)
Cryogenic- and room-temperature electron microscopy imaging of MDA231 breast cancer cells and microparticles using immunogold labeling (2012) (1)
First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry (2020) (1)
Thrombosis in Pregnant Women with Hemolytic Anemia (2022) (1)
Venous thromboembolism: advances and controversies. Preface. (2012) (1)
[Warfarin therapy and hemarthrosis]. (2010) (1)
Pregnancy should not rule out 18FDG PET/CT for women with cancer – Authors' reply (2012) (1)
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review (2022) (1)
Thrombotic complications in patients with cancer: Advances in pathogenesis, prevention, and treatment—A report from ICTHIC 2021 (2022) (1)
Associations of maternal and placental extracellular vesicle miRNA with preeclampsia (2023) (1)
Inverse PAR1 Activity of Hematopoietic Stem Cells and BM Stromal Cells Mediates G-CSF-Induced Mobilization By Regulation of Nitric Oxide Generation (2016) (1)
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism (2021) (1)
Women's Issues in Thrombophilia (2003) (1)
Thrombophilia in Pregnancy and its Role in Abortion (2005) (1)
Heparanase Activation of the Coagulation System in a Mice Sepsis Model (2011) (1)
Coexistence of acquired protein S and protein C deficiency and the Arg506Gln mutation in factor Va in a child with severe thromboembolic disease (1998) (1)
Low-Molecular-Weight Heparin in Pregnancy: State of the Art (2005) (1)
3 Microparticles have procoagulant and apoptotic effects on endothelial cells (2007) (1)
Cancer and thrombosis. (2009) (1)
Are platelet membrane glycoprotein polymorphisms predictive of arterial thrombosis? (2002) (1)
Highlights of the 45th Annual Meeting of the American Society of Hematology (2004) (1)
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism. (2023) (1)
Author Response: Precise Staging of Lymphoma during Pregnancy Using MRI is Not Always Crucial (2015) (1)
Phase 3, Placebo-Controlled, ASPIRE Study (TRC114968) of Eltrombopag (EPAG) Treatment of Thrombocytopenia (TCP) in Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Assessment of Clinical Benefit, Safety, and Tolerability (2015) (1)
C0292: The Role of Breast Cancer Cell Microparticles in Thrombogenicity, Angiogenesis and Apoptosis Following Chemotherapy (2014) (1)
Managing thrombophilia during pregnancy (2010) (1)
Papers and abstracts of the 9th International Conference on Thrombosis and Hemostasis Issues in Cancer (April 13-15, 2018-Bergamo, Italy) (2014) (0)
Profile Of Microparticles In Patients With Acute Leukemia At Diagnosis and Upon Remission Induction (2013) (0)
Thrombosis and Haemostasis Issues in Cancer: 2nd International Conference, Bergamo, September 2003: Lectures and Abstracts (2003) (0)
Comparison of guidelines for evaluation of suspected PE in pregnancy: a cost-effectiveness analysis. (2021) (0)
RECORD2: extended thromboprophylaxis with rivaroxaban versus short-term thromboprophylaxis with enoxaparin after total hip replacement (2008) (0)
CA-125 as a Marker for the Early Diagnosis of Hepatic Veno-Occlusive Disease Following Hematopoietic Stem Cell Transplantation. (2004) (0)
Thrombosis and Antithrombotic Therapy Reviewed (2001) (0)
Low-molecular-weight heparin in women with repeated implantation failure (Women's Health (2011) 7: 4 (424-431)) (2011) (0)
0.09a Microparticles' effect on apoptosis, angiogenesis and migration in healthy and pathological pregnancies (2011) (0)
Proceedings of the Fifth International Conference on Thrombosis and Hemostasis Issues in Cancer, held in Stresa, Italy, April 23-25, 2010. Preface. (2010) (0)
Silent Pulmonary Embolism in Patients with Lower Limb Deep Vein Thrombosis (2011) (0)
Maternal and Neonatal Hemostasis (2023) (0)
Co-Interaction and Increased Release of Tissue Factor Pathway Inhibitor by Heparanase. (2005) (0)
[New scoring system for estimating the risk for pregnancy complications and venous thromboembolism in women with thrombophilia]. (2011) (0)
Lymphoma and Leukemia during Pregnancy (2013) (0)
Microvesicles microRNAs Reflect and Affect Progression of Acute Myeloid Leukemia and Could Serve As a Biomarker of Disease Dynamics (2016) (0)
[Budd-Chiari syndrome in polycythemia following phlebotomy]. (1985) (0)
6A.3 Debate: Antithrombotics for prevention of pregnancy loss – Yes (2007) (0)
Should thromboprophylaxis be used in hereditary thrombophilias with RPL?: – For (2007) (0)
5. Severe thrombotic diathesis resulting from coexistence of dysfibrinogenemia and factor V Leiden (1996) (0)
P-002: p45-NF-E2 regulates syncytiotrop formation in human placenta by modulation GCM-1 post translational modifications (2017) (0)
6th International Conference on Thrombosis and Hemostasis Issues in Cancer. Preface. (2012) (0)
International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients (2012) (0)
Can we program VTE prevention in pregnancy? (2015) (0)
RECOMMENDED ARTICLE OF THE MONTH Comment on "Fibrinolysis for patients with intermediate-risk pulmonary embolism" (2015) (0)
[Fever and neutropenias]. (1985) (0)
7th international conference on thrombosis and hemostasis issues in cancer. Preface. (2014) (0)
Debate: Should Thromboprophylaxis Be Used in Hereditary Thrombophilias with Recurrent Pregnancy Loss? Yes (2014) (0)
Inherited bleeding disorders in women (2002) (0)
Effects of initial whole blood hematocrit on quantitative ultrasonic backscatter from blood clots in vitro (1989) (0)
45 Effect of fibrin matrices on increased proliferation and spreading of pre-term trophoblasts and placental villi modulation of coagulation and angiogenesis functions (2007) (0)
P020: The management of pregnancy in a patient with hereditary combined deficiency of vitamin K dependent factors (2019) (0)
C-deficient newborn with massive thrombosis large family of a previously described homozygous protein R506Q mutation of factor V and for T298M mutation of protein C in a Venous thromboembolism associated with double heterozygosity for (2011) (0)
P-060: OTTILIA and FIRST: two international registries of foeto-maternal prognosis in women with recurrent reproductive failures after spontaneous or assisted conception (2017) (0)
The role of breast cancer cell microparticles in thrombogenicity and angiogenesis following chemotherapy (2012) (0)
Involvement of Heparanase in Early Pregnancy Losses (2008) (0)
Abstract 5046: Nitric Oxide and Superoxide Dismutase Modulate Endothelial Progenitor Cell Function in Type 2 Diabetes Mellitus (2009) (0)
Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate (2016) (0)
Preface to the Proceedings of the 11th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2022. (2022) (0)
Postsplenectomy pericardial effusion in two patients with myeloid metaplasia. (1986) (0)
mutation in the leucine-rich domain of glycoprotein IX Variant Bernard-Soulier syndrome associated with a homozygous (2011) (0)
P8 Corpus luteum hemorrhage in women with bleeding disorders (2009) (0)
Myeloproliferative neoplasms in pregnancy: ways to go (2016) (0)
Antiphospholipid syndrome, heritable thrombophilia and early pregnancy loss (2008) (0)
Abstracts from the Fourteenth Rambam Research Day, December 7, 2017 (2018) (0)
The use of thrombophilia and pharmacological thromboprophylaxis screening in women: The benefits of the RIETE registry (2017) (0)
Could arterial atherosclerosis herald cancer diagnosis? (2021) (0)
An Open Label, Multi Center Study on the Efficacy and Safety of a Liquid, Ready-to-Use Intravenously Administered Anti-D Immunoglobulin in Patients with Chronic Immune Thrombocytopenic Purpura. (2004) (0)
"Hematological malignancies occurring in pregnancy, although uncommon, present major diagnostic and therapeutic challenges." (2013) (0)
P-001: Microparticles cause preeclampsia and embryonic growth restriction by platelet-mediated inflammasome activation in the embryonic trophoblast (2017) (0)
of More Recent European Origin Another From Distinct Founders: One of Ancient Middle Eastern Origin and The Two Common Mutations Causing Factor XI Deficiency in Jews Stem (2013) (0)
Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes ("pre-ATL") in a 20-year follow-up study (2017) (0)
P7 Microparticles from women with gestational vascular complications (GVC) induce cells apoptosis and impaired tube formation (2009) (0)
Role of Soluble Crosslinked Fibrin Polymers (2005) (0)
HSP70 Is Increased in Circulating Extracellular Vesicles from Transfusion-Dependent β-Thalassemia Patients: Potential Biomarker for Ineffective Erythropoiesis (2016) (0)
RECURRENT VENOUS THROMBOEMBOLISM IN PULMONARY EMBOLISM PATIENTS WITH RIGHT VENTRICULAR DYSFUNCTION IN THE HOKUSAI-VTE STUDY (2016) (0)
Abstracts from Rambam Research Day, December 11, 2014 (2015) (0)
Abstracts from the Thirteenth Rambam Research Day, December 22, 2016 (2017) (0)
Superior vena cava thrombosis as a presenting syndrome of malignancy in a patient with lupus anticoagulant and hereditary protein C deficiency (1991) (0)
AN EVALUATION OF THE EFFICACY AND SAFETY OF EXTENDED THROMBOPROPHYLAXIS WITH ORAL RIVAROXABAN COMPARED WITH SHORTTERM SUBCUTANEOUS ENOXAPARIN FOLLOWING TOTAL HIP REPLACEMENT (RECORD2: A PHASE III STUDY) (2010) (0)
PAPER 147: RECORD2: A PHASE III EVALUATION OF THE EFFICACY AND SAFETY OF EXTENDED THROMBOPROPHYLAXIS WITH RIVAROXABAN COMPARED WITH SHORT-TERM ENOXAPARIN FOLLOWING TOTAL HIP REPLACEMENT (2010) (0)
C0431 Microparticle TF/ TFPI Hemostatic Balance in Physiological and Pathological States (2012) (0)
[ACQUIRED HEMOPHILIA A AND THE TIMING OF IMMUNOMODULATORY THERAPY]. (2019) (0)
Identifying Women at High Risk of Venous Thrombosis before Administration of Hormone Therapy (2007) (0)
[Sentinel lymph node sampling in breast carcinoma]. (2000) (0)
NORMAL RESPONSE OF FACTOR (F)-VIII AND VONWILLEBRAND FACTOR (VWF) TO DDAVP IN NEPHRDGENIC DIABETES INSIPIDUS (NDI)) (1987) (0)
Protein C global assay evaluation in naturally conceived vs. assisted reproduction-achieved twin pregnancies: a prospective longitudinal study (2021) (0)
Binding of immunoglobulin from patients with lupus anticoagulant to endothelial cells ? Possible association with thrombosis (1992) (0)
Deficiency of All Vitamin K-Dependent Blood Coagulation Factors -Glutamyl Carboxylase Gene Causes Combined γ A Missense Mutation in (2012) (0)
P046: Proposed methodology to determine the optimal diagnostic strategy for pregnant women with suspicion of pulmonary embolism (2019) (0)
Improving pregnancy outcome in women with thrombophilia (2004) (0)
Thrombophilia and the Risk of Venous Thromboembolism in Cancer (2004) (0)
Inhaled beta2-adrenoreceptor agonist elicits hypercoagulability state (2011) (0)
The International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) at the Peak of Adolescence - 15 Years and Counting. (2016) (0)
Expression and Characterization of the Naturally Occurring Mutation L394R in Human Î3-Glutamyl Carboxylase* (2000) (0)
PROPHYLAXIS AND TREATMENT OF THROMBOEMBOLISM I THROMBOPHILIA AND PREGNANCY COMPLICATIONS (2008) (0)
The impact of heparanase on cancer progression (2009) (0)
Author's reply to: Al-Abdi SY. Virus-inactivated plasma and intraventricular hemorrhage in preterm neonates (2014) (0)
How to calculate the maximum risk— reply (1994) (0)
456 The involvement of placental and extracellular vesicles micro-RNA in the pathophysiology of gestational vascular complications (2021) (0)
Editorial: Thrombotic Disorders, Prothrombotic Abnormalities and COVID-19 (2021) (0)
Preface to the Proceedings of the 10th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2020 (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Benjamin R. Brenner?

Benjamin R. Brenner is affiliated with the following schools: